Table 4.
Bivariate analysis of factors influencing HADS-Anxiety
| VARIABLE | HADS Anxiety | P Value |
|---|---|---|
| Age (correlation) | -0,059 | 0,522 |
| Steroid duration, correlation | -0,153 | 0,095 |
| C3 levels, correlation | 0,189 | 0,038 |
| C4 levels, correlation | -0,185 | 0,043 |
| Mex-SLEDAI | 0,173 | 0,06 |
| Marital Status, median (IQR) | ||
| Unmarried | 5 (4,5) | 0,220 |
| Married | 6 (5) | |
| Divorced | 8,5 (12,5) | |
| Organ Involvement, | ||
| Mucocutaneous, median (IQR) | 0,763 | |
| Yes | 5 (4) | |
| No | 5 (7,25) | |
| Musculoskeletal, median (IQR) | 0,21 | |
| Yes | 5 (4,25) | |
| No | 7,5 (7,5) | |
| Hematology, median (IQR) | 0,973 | |
| Yes | 6 (4,25) | |
| No | 5 (5) | |
| Kidney, median (IQR) | 0,45 | |
| Yes | 5 (4) | |
| No | 5 (5) | |
| Serositis, median (IQR) | 0,08 | |
| Yes | 6 (4,5) | |
| No | 5 (5) | |
| DMARD | ||
| Azathioprine, median (IQR) | 0,055 | |
| Yes | 4 (3) | |
| No | 6 (5) | |
| Cyclosporine, median (IQR) | 0,558 | |
| Yes | 6 (2) | |
| No | 5 (4) | |
| HCQ, median (IQR) | 0,838 | |
| Yes | 5 (4) | |
| No | 5 (5,5) | |
| Mycophenolate, median (IQR) | 0,531 | |
| Yes | 5 (5) | |
| No | 5 (4,25) | |
C3 complement 3, C4 complement 4, DMARD Disease-Modifying Antirheumatic Drugs, HADS A Hospital Anxiety and Depression Scale for anxiety, HADS-D Hospital Anxiety and Depression Scale for depression, HCQ Hydroxychloroquine, Mex SLEDAI Mexican systemic lupus erythematosus systemic disease activity